A Stuty on the Treatment and Nursing Care of CIPN Patients With Traditional Chinese Medicine Hot Package

Launched by THE FOURTH AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE · Jul 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how a specific treatment using traditional Chinese medicine hot packs can help patients who experience nerve damage from chemotherapy, a condition known as chemotherapy-induced peripheral neuropathy (CIPN). CIPN can cause painful symptoms that affect daily activities and overall quality of life. The trial aims to see if these hot packs can improve nerve health in patients receiving a combination of two chemotherapy drugs, platinum and paclitaxel.

To participate, you need to be an adult patient expected to survive with cancer for more than a year and starting chemotherapy with platinum and paclitaxel for the first time. You should be willing to join the study and sign a consent form. However, if you have certain conditions such as allergies to these medications or specific nerve issues, you might not be eligible. If you join, you'll learn how to use the hot packs at home, making it easier to manage your symptoms without frequent hospital visits. This approach is designed to be simple, with the hope of improving your comfort and wellbeing during your treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult and kinetic patients expected survive with tumor for more than 1 year. Those who use platinum in combination with paclitaxel for chemotherapy for the first time; Voluntarily agree to participate and sign a consent form
• Exclusion Criteria:
• • Those who are allergic to platinum, paclitaxel or Chinese herbal medicine ingredients; Patients with diabetes mellitus, Raynaud's syndrome, central or peripheral nerve disease symptoms; Those who cannot judge their own symptoms; Pregnant / lactating women; Patients with advanced rheumatoid arthritis, severe joint deformity or incapacitation; Those with other immune system diseases； Patients who have not completed the chemotherapy regimen; Patients who were not treated with hot acupuncture points as prescribed (missed dosing ≥ 3 times per week); Incomplete collection of clinical data; Subjects who voluntarily request to withdraw from this treatment, or are unwilling to continue treatment.